Toward better treatment of congenital adrenal hyperplasia.
Speiser
P W
PW
New York University School of Medicine, New York, NY 11030, USA.
D042842:11-beta-Hydroxysteroid Dehydrogenases; D000312:Adrenal Hyperplasia, Congenital / Q000628:therapy*; D000328:Adult; D002229:Carbenoxolone / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D008297:Male; D008901:Mineralocorticoids / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D008901:Mineralocorticoids; D006913:Hydroxysteroid Dehydrogenases; D042842:11-beta-Hydroxysteroid Dehydrogenases; D002229:Carbenoxolone; D005438:Fludrocortisone; D006854:Hydrocortisone